Becton Dickinson & Co (BDX) stock
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3018% above fair value
$216.47−1.56 (-0.72%)
Close on Nov 16, 2026Market cap $58.96BP/E 65.4Yield 1.92%
Becton Dickinson revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Becton Dickinson's revenue for the twelve months ending Jun 30, 2026 was $23.25B, up 17.4% year over year. For fiscal 2025 it was $21.84B, up 8.2% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $21.84B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $21.84B | +8.2% |
| FY2024 | Sep 30, 2024 | $20.18B | +4.2% |
| FY2023 | Sep 30, 2023 | $19.37B | +2.7% |
| FY2022 | Sep 30, 2022 | $18.87B | -1.4% |
| FY2021 | Sep 30, 2021 | $19.13B | +19.0% |
| FY2020 | Sep 30, 2020 | $16.07B | -7.0% |
| FY2019 | Sep 30, 2019 | $17.29B | +8.2% |
| FY2018 | Sep 30, 2018 | $15.98B | +32.2% |
| FY2017 | Sep 30, 2017 | $12.09B | -3.1% |
| FY2016 | Sep 30, 2016 | $12.48B | +21.4% |
| FY2015 | Sep 30, 2015 | $10.28B | +21.7% |
| FY2014 | Sep 30, 2014 | $8.45B | +4.9% |
| FY2013 | Sep 30, 2013 | $8.05B | +4.5% |
| FY2012 | Sep 30, 2012 | $7.71B | +1.6% |
| FY2011 | Sep 30, 2011 | $7.58B | +6.5% |
| FY2010 | Sep 30, 2010 | $7.12B | +2.0% |
| FY2009 | Sep 30, 2009 | $6.99B | +1.3% |
| FY2008 | Sep 30, 2008 | $6.90B | +9.8% |
| FY2007 | Sep 30, 2007 | $6.28B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $4.98B | +5.4% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $4.71B | +5.2% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $5.25B | +1.6% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $8.30B | +52.7% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $4.73B | -5.3% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $4.48B | -11.2% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $5.17B | +9.8% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $5.44B | +6.9% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $4.99B | +2.3% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $5.05B | +4.6% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $4.71B | +2.6% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $5.09B | +6.8% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $4.88B | +5.1% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $4.82B | +1.5% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $4.59B | -2.8% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $4.76B | -1.8% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $4.64B | +0.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $4.75B | -3.2% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $4.72B | -11.2% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $4.85B | +1.4% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $4.61B | +19.5% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $4.91B | +15.4% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $5.32B | +25.8% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $4.78B | +4.4% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $3.86B | -11.4% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $4.25B | +1.4% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $4.23B | +1.6% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $4.58B | +4.1% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $4.35B | +1.7% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $4.20B | -0.6% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $4.16B | +35.1% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $4.40B | +39.0% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $4.28B | +41.0% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $4.22B | +42.2% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $3.08B | +5.4% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $3.17B | -2.0% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $3.04B | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $2.97B | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $2.92B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $3.23B | – |
See a number that looks wrong?